Search Within

Ann Jakubowski

Formats
  1. Meeting Abstract (247)
  2. Journal Article (194)
  3. Research Letter (8)
  4. Review (4)
  5. Book Section (3)
  6. Conference Paper (2)
  7. Correspondence (1)
Groups
  1. Bone Marrow Transplant (459)
  2. Center for Hematologic Malignancies (459)
  3. Department of Medicine (459)
  4. Hematologic Malignancies, Division of (459)
  5. Survivorship Research (459)
  6. Sloan Kettering Institute Faculty (190)

More Groups

People
  1. Esperanza Papadopoulos (256)
  2. Miguel-Angel Perales (248)
  3. Sergio Giralt (242)
  4. Hugo Castro-Malaspina (185)
  5. James Young (155)
  6. Richard O'Reilly (145)

More People

Years
  1. 2025 (5)
  2. 2024 (6)
  3. 2023 (14)
  4. 2022 (18)
  5. 2021 (17)
  6. 2020 (25)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (150)
  2. Blood (118)
  3. Bone Marrow Transplantation (42)
  4. Blood Advances (12)
  5. Leukemia and Lymphoma (11)
  6. Transplantation and Cellular Therapy (11)

More Publications

Publishers
  1. Elsevier Inc. (165)
  2. American Society of Hematology (130)
  3. Nature Publishing Group (44)
  4. Wiley Blackwell (13)
  5. Oxford University Press (11)
  6. Taylor & Francis Group (11)

More Publishers

Results (459)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel Cy/ Flu/ Thio/ TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Toxicities associated with high dose chemotherapy and autologous stem cell transplantation in older patients with non-Hodgkin lymphoma
    Meeting Abstract

    Dahi, P. B.; Rondon Clavo, C.; Maloy, M.; Seier, K.; Devlin, S. M.; Robinson, K.; Scordo, M.; Shah, G. L.; Tamari, R.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Empiric anti-thymocyte globulin (ATG) dosing in ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (allo-HCT) may result in ATG overexposure that negatively affects outcomes
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Smith, M.; Thoren, K.; Hilden, P.; Cho, C.; Shah, G. L.; Maloy, M.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Impact of toxicity on survival for older adult patients after CD34(+) selected allogeneic hematopoietic stem cell transplantation
    Journal Article

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Borrill, T.; Carlow, D. C.; Avecilla, S. T.; Meagher, R. C.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Beyer, K.; Proli, A. J.; Zheng, J. T.; Bhatt, V.; Lin, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Perales, M. A.; Castro-Malaspina, H.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Graft-versus host disease (GVHD status and severity mediate late effects of allogeneic hematopoietic stem cell transplantation (HSCT) in a 1-year landmark analysis
    Meeting Abstract

    Sola, M.; Devlin, S. M.; Maloy, M.; Dierov, D.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Development of and compliance with a vitamin D monitoring and supplementation program for hematopoietic stem cell transplant (HSCT) patients
    Meeting Abstract

    Collum, K.; Featherstone, C.; Beyer, K.; Farooki, A.; Hylton, H. M.; Irby, S.; Kelly, S.; Kenny, S.; Morcerf, B.; Patterson, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Combining the disease risk index (DRI) and hematopoietic cell transplantation comorbidity index (HCT-CI) provides a comprehensive prognostic model for CD34-selected allogeneic HCT
    Meeting Abstract

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Maloy, M.; Meagher, R.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save